These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37973549)

  • 21. The German Fast Track Toward Reimbursement of Digital Health Applications: Opportunities and Challenges for Manufacturers, Healthcare Providers, and People With Diabetes.
    Schliess F; Affini Dicenzo T; Gaus N; Bourez JM; Stegbauer C; Szecsenyi J; Jacobsen M; Müller-Wieland D; Kulzer B; Heinemann L
    J Diabetes Sci Technol; 2024 Mar; 18(2):470-476. PubMed ID: 36059268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evidence of positive care effects by digital health apps-methodological challenges and approaches].
    König IR; Mittermaier M; Sina C; Raspe M; Stais P; Gamstätter T; Stachwitz P; Wolfrum S; Richter JG; Möckel M;
    Inn Med (Heidelb); 2022 Dec; 63(12):1298-1306. PubMed ID: 36279007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DiGA in Primary Care and the Influence of Patient-Related Factors - Results of a Survey of Family Doctors.
    Brecher AL; Herrgen J; Mueller T
    Stud Health Technol Inform; 2024 Apr; 313():55-61. PubMed ID: 38682505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The three-year evolution of Germany's Digital Therapeutics reimbursement program and its path forward.
    Schmidt L; Pawlitzki M; Renard BY; Meuth SG; Masanneck L
    NPJ Digit Med; 2024 May; 7(1):139. PubMed ID: 38789620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Digital health applications (DiGA) in medical and psychotherapeutic care. Opportunities and challenges from the perspective of the healthcare providers].
    Gerlinger G; Mangiapane N; Sander J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Oct; 64(10):1213-1219. PubMed ID: 34550412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One year of digital health applications (DiGA) in Germany - Rheumatologists' perspectives.
    Richter JG; Chehab G; Stachwitz P; Hagen J; Larsen D; Knitza J; Schneider M; Voormann A; Specker C
    Front Med (Lausanne); 2022; 9():1000668. PubMed ID: 36388899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence of How Physicians and Their Patients Adopt mHealth Apps in Germany: Exploratory Qualitative Study.
    Schroeder T; Haug M; Georgiou A; Seaman K; Gewald H
    JMIR Mhealth Uhealth; 2024 Jan; 12():e48345. PubMed ID: 38231550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Technology assessment of digital health applications for reimbursement decisions].
    Jeindl R; Wild C
    Wien Med Wochenschr; 2024 Mar; 174(3-4):44-52. PubMed ID: 34529150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Critical Evaluation of Permanently Listed Psychosocial Digital Health Applications into the Directory for Reimbursable Digital Health Applications of the BfArM].
    Wolff LL; Rapp M; Mocek A
    Psychiatr Prax; 2023 Mar; 50(2):67-79. PubMed ID: 36170874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Telemonitoring and eHealth for arterial hypertension : Status quo and perspectives].
    Beger C; Haller H; Limbourg FP
    Internist (Berl); 2021 Mar; 62(3):263-268. PubMed ID: 33580308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acceptance of digital health applications in non-pharmacological therapies in German statutory healthcare system: Results of an online survey.
    Frey S; Kerkemeyer L
    Digit Health; 2022; 8():20552076221131142. PubMed ID: 36506488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postmarketing Follow-Up of a Digital Home Exercise Program for Back, Hip, and Knee Pain: Retrospective Observational Study With a Time-Series and Matched-Pair Analysis.
    Teepe GW; Kowatsch T; Hans FP; Benning L
    J Med Internet Res; 2023 Feb; 25():e43775. PubMed ID: 36848211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Problems and Barriers Related to the Use of Digital Health Applications: Protocol for a Scoping Review.
    Giebel GD; Speckemeier C; Abels C; Börchers K; Wasem J; Blase N; Neusser S
    JMIR Res Protoc; 2022 Apr; 11(4):e32702. PubMed ID: 35451979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated, cross-sectoral psycho-oncology (isPO): a new form of care for newly diagnosed cancer patients in Germany.
    Kusch M; Labouvie H; Schiewer V; Talalaev N; Cwik JC; Bussmann S; Vaganian L; Gerlach AL; Dresen A; Cecon N; Salm S; Krieger T; Pfaff H; Lemmen C; Derendorf L; Stock S; Samel C; Hagemeier A; Hellmich M; Leicher B; Hültenschmidt G; Swoboda J; Haas P; Arning A; Göttel A; Schwickerath K; Graeven U; Houwaart S; Kerek-Bodden H; Krebs S; Muth C; Hecker C; Reiser M; Mauch C; Benner J; Schmidt G; Karlowsky C; Vimalanandan G; Matyschik L; Galonska L; Francke A; Osborne K; Nestle U; Bäumer M; Schmitz K; Wolf J; Hallek M
    BMC Health Serv Res; 2022 Apr; 22(1):543. PubMed ID: 35459202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Digitalization of healthcare and its effects on quality of care].
    Brönneke JB; Debatin JF
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Mar; 65(3):342-347. PubMed ID: 35181795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can we use existing guidance to support the development of robust real-world evidence for health technology assessment/payer decision-making?
    Capkun G; Corry S; Dowling O; Asad Zadeh Vosta Kolaei F; Takyar S; Furtado C; Jónsson P; Kleinermans D; Lambert L; Schiel A; Facey K
    Int J Technol Assess Health Care; 2022 Nov; 38(1):e79. PubMed ID: 36321447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of real-world data and evidence for medical devices: a qualitative study of key informant interviews.
    Polisena J; Jayaraman G
    Int J Technol Assess Health Care; 2020 Dec; 36(6):579-584. PubMed ID: 33161916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward.
    Lou J; Kc S; Toh KY; Dabak S; Adler A; Ahn J; Bayani DBS; Chan K; Choiphel D; Chua B; Genuino AJ; Guerrero AM; Kearney B; Lin LW; Liu Y; Nakamura R; Pearce F; Prinja S; Pwu RF; Shafie AA; Sui B; Suwantika A; Teerawattananon Y; Tunis S; Wu HM; Zalcberg J; Zhao K; Isaranuwatchai W; Wee HL
    Int J Technol Assess Health Care; 2020 Oct; 36(5):474-480. PubMed ID: 32928330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies.
    Makady A; Ham RT; de Boer A; Hillege H; Klungel O; Goettsch W;
    Value Health; 2017 Apr; 20(4):520-532. PubMed ID: 28407993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Digital health applications-patient-centric care with disruptive potential].
    Ryll B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Oct; 64(10):1207-1212. PubMed ID: 34477883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.